๐ฐ Genentech News
Page 199 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
February 24, 2023
This month, our Women Taking the Lead program sat down with Quita Highsmith, VP and Chief Diversity Officer for Genetech.
February 24, 2023
The FDA approved efanesoctocog alfa, a once-weekly treatment for children and adults with hemophilia A.The approval applies to use of the factor VIII replacement therapy as routine prophylaxis to reduce the frequency of bleeding episodes, on-demand treatment for control of bleeds, and for perioperative management of bleeding. Efanesoctocog alfa (Altuviiio; Bioverativ Therapeutics, Sanofi) is not
February 24, 2023
The US Court of Appeals for the Ninth Circuit concluded that when a party obtains a declaratory relief finding that it does not infringe a trademark, it no longer has Article III...
February 24, 2023
The global Biliary Tract Cancers (BTCs) treatment market is expected to witness steady growth in the coming years, according to a new report published by a leading market research firm. The report provides insights into the current market scenario, trends, drivers, challenges, and opportunities in the BTCs treatment...
February 23, 2023
Investegate announcements from Oxford BioDynamics, PDMR Dealing
February 23, 2023
Recent advances in cancer genomics have deepened the medical community's understanding of the molecular alterations in brain tumours, more precisely subclassifying patients into specific diagnoses. Understanding
February 23, 2023
SAN DIEGO - Clinicians must rule out several neurological diseases that often mimic MS when making a diagnosis, according to a presenter at ACTRIMS 2023. “For medical students or trainees involved in MS diagnosis, it’s important to show these are not the zebras that are misdiagnosed but are actually common conditions that we see in our clinics,” Eoin P. Flanagan, MB, BCh,
February 22, 2023
Genentech is expanding its manufacturing capabilities in Oceanside. The biologics facility is set to open by early 2025.
February 22, 2023
Nobel Prize-winning biochemist Paul Berg, whose experiments reshaped cancer research and spawned the biotech industry, dies
February 21, 2023
As startups refocus on โoperational efficiency,โ letโs emphasize that efficiency is a way of working, not your headcount. Agile development has been the #1 operational principle of tech for over 20โฆ